Contact Us

The choice depends on whether you are studying SRPK1's role in SR protein phosphorylation and pre-mRNA splicing regulation, or its emerging functions in cancer biology and viral RNA processing. The Knockout line is the standard tool for asking whether SRPK1 is required for SR protein phosphorylation of splicing factors (SRSF1-12 family). Overexpression is useful for studying SRPK1 overexpression effects in cancer or for testing sufficiency in splicing modulation. For splicing research, the EDITGENE SRPK1 Knockout in HAP1 is informative for dissecting SRPK1-dependent splicing events, though SRPK2 paralog compensation should be considered for SR protein phosphorylation readouts. Rescue with wild-type or kinase-dead SRPK1 is the standard specificity control. SRPK1 inhibitors (e.g., SRPIN340) are in development for cancer and viral disease — the knockout serves as a critical genetic specificity control.

Yes. SRPK1 rescue experiments require attention to its splicing kinase activity and localization: • Construct design: use a codon-modified SRPK1 sequence with a small C-terminal tag (FLAG, HA). SRPK1 contains a bipartite kinase domain interrupted by a spacer region — all elements should be preserved. • Kinase-dead rescue: the K109R mutation in the ATP-binding lysine abolishes catalytic activity and is the standard specificity control for distinguishing kinase from non-catalytic functions. • Cytoplasmic/nuclear localization: SRPK1 shuttles between cytoplasmic and nuclear compartments — confirm exogenous SRPK1 localization patterns approximate endogenous distribution. • Paralog considerations: SRPK2 expression analysis helps interpret SR protein phosphorylation rescue. HAP1-specific considerations: • Diploidization: HAP1 cells gradually diploidize during extended culture — confirm ploidy by flow cytometry at the time of phenotypic assay. • Integration site sensitivity: position effects on transgene expression are more pronounced in near-haploid backgrounds; generating multiple independent rescue clones is strongly recommended. • Transduction efficiency: HAP1 transduces with lentivirus at moderate efficiency — increase MOI compared to standard immortalized lines.

The choice depends on whether you are studying SARM1's role as the central executioner of axon degeneration or its enzymatic activity as a NAD⁺ glycohydrolase. The Knockout line is the standard tool for asking whether SARM1 is required for activation-induced NAD⁺ depletion — SARM1 is a dormant NAD⁺ hydrolase that, upon activation by NMN/NAD⁺ ratio increase or injury, catalyzes catastrophic NAD⁺ destruction triggering Wallerian axon degeneration. Overexpression is useful for studying constitutively active SARM1 mutants (E642A) or testing inhibitor specificity. For SARM1 research, the EDITGENE Knockout in HEK293 is the standard mechanistic platform — HEK293 has been extensively used for SARM1 biochemistry, structure-function studies, and inhibitor screening. Rescue with wild-type, catalytically-dead (E642A or constitutively active depending on the mutation), or autoinhibition-released SARM1 enables comprehensive mechanism studies. SARM1 is a major therapeutic target for chemotherapy-induced peripheral neuropathy, diabetic neuropathy, and other axonopathies — multiple SARM1 inhibitors are in clinical development.

Yes. SARM1 rescue experiments are well-established for axon degeneration research: • Construct design: use a codon-modified SARM1 sequence with a small C-terminal tag (FLAG, HA). SARM1 contains an N-terminal mitochondrial targeting sequence/ARM autoinhibitory domain, central SAM dimerization domain, and C-terminal TIR catalytic domain — all essential for regulated activation. • Catalytically-dead rescue: the E642A mutation in the TIR domain abolishes NAD⁺ hydrolase activity and is the standard specificity control. • Constitutively active rescue: ARM domain mutations or deletions release autoinhibition, generating constitutively active SARM1 useful for gain-of-function studies. • Functional readout: rescue should restore activation-induced NAD⁺ depletion measured by NAD⁺/NADH ratio assays following NMN treatment or other activation triggers. HEK293 transduces efficiently with lentivirus and is the standard heterologous expression background for SARM1 biochemistry.

The choice depends on whether you are studying SIRT5's role as a unique mitochondrial desuccinylase/demalonylase/deglutarylase or its emerging functions in metabolic regulation and cancer. The Knockout line is the standard tool for asking whether SIRT5 is required for removing these acidic PTMs from mitochondrial substrates — SIRT5 is the only mammalian sirtuin with substantial desuccinylation/demalonylation activity, distinguishing it functionally from the other six sirtuins. Overexpression is useful for testing SIRT5 in metabolic stress contexts or for assessing its role in cancer biology. For sirtuin research, the EDITGENE SIRT5 Knockout in HEK293 is the standard mechanistic platform — HEK293 supports the biochemical and proteomic analyses needed for SIRT5 substrate characterization. Rescue with wild-type or catalytically-dead (H158Y) SIRT5 is the standard specificity control. The knockout serves as a critical genetic specificity tool for SIRT5-selective compounds in development.

Yes. SIRT5 rescue experiments require attention to mitochondrial targeting and catalytic activity: • Construct design: use a codon-modified SIRT5 sequence with a small C-terminal tag (FLAG, HA). SIRT5 contains an N-terminal mitochondrial targeting sequence — N-terminal tags must not disrupt mitochondrial import. • Catalytically-dead rescue: the H158Y mutation abolishes desuccinylase/demalonylase activity and is the standard specificity control. • Mitochondrial localization validation: confirm mitochondrial localization by TOM20 co-staining or mitochondrial fractionation before functional assays. • Functional readout: rescue should restore desuccinylation of SIRT5 substrates measured by anti-succinyl-lysine Western blot. HEK293 transduces efficiently with lentivirus and supports stable rescue line generation.

The choice depends on whether you are studying SENP8 (also known as DEN1/NEDP1)'s role as the principal NEDD8-specific protease or its functions in regulating cullin-RING E3 ligase activity. Important note: despite the 'SENP' (SUMO-Specific Protease) name, SENP8 is a NEDD8-specific protease, not a SUMO protease. It is essential for processing the NEDD8 precursor and for deconjugating NEDD8 from non-cullin substrates. The Knockout line is the standard tool for asking whether SENP8 is required for these processes — SENP8 loss disrupts NEDD8 homeostasis and impairs cullin neddylation regulation. For NEDD8 biology research, the EDITGENE SENP8 Knockout in HEK293 is a mechanistic platform — HEK293 supports the biochemical and proteomic analyses needed for NEDD8 substrate characterization. Rescue with wild-type or catalytically-dead (C163S) SENP8 is the standard specificity control. The knockout is valuable for studying neddylation pathway regulation and for testing NEDD8 pathway inhibitors (MLN4924/pevonedistat) in mechanism research.

Yes. SENP8 rescue experiments are well-established for NEDD8 pathway research: • Construct design: use a codon-modified SENP8 sequence with a small C- or N-terminal tag (FLAG, HA). SENP8 is small (~212 amino acids); both tag positions are typically tolerated. • Catalytically-dead rescue: the C163S mutation in the active site cysteine abolishes deNEDDylase activity and is the standard specificity control. • Functional readout: rescue should restore NEDD8 precursor processing (mature NEDD8 generation) and cullin neddylation status. • MLN4924 mechanism studies: rescue with wild-type or catalytically-dead SENP8 enables on-target validation of NEDD8 E1 inhibitor pevonedistat effects. HEK293 transduces efficiently with lentivirus and supports stable rescue line generation.

The choice depends on whether you are studying SLC19A1 (RFC, reduced folate carrier)'s classical role in folate/antifolate drug uptake or its breakthrough function as the 2'3'-cGAMP importer in innate immune signaling. The Knockout line is the standard tool for both — SLC19A1 is the principal cellular importer of reduced folates, methotrexate, and pemetrexed, AND was identified in 2019 as the major importer of 2'3'-cGAMP for STING-dependent innate immune sensing. Overexpression is useful for testing methotrexate sensitivity or for studying STING agonist pharmacology. For innate immunity research, the EDITGENE SLC19A1 Knockout in HEK293 is a high-value mechanistic tool — extracellular STING agonists (cyclic dinucleotides, ADU-S100, MSA-2 prodrugs, others) often require SLC19A1 for cellular entry. This product complements the parallel SLC19A1 Knockout in HCT 116 (also available); HEK293 is preferred for STING reporter assays and methotrexate biochemistry. Rescue with wild-type or transport-deficient SLC19A1 enables structure-function studies of both folate and cGAMP transport.

Yes. SLC19A1 rescue experiments are well-established for both folate and cGAMP transport research: • Construct design: use a codon-modified SLC19A1 sequence with a small C-terminal tag (FLAG, HA). SLC19A1 has 12 transmembrane domains. • Transport-deficient rescue: substrate-binding pocket mutations enable structure-function studies — separate rescue with folate-transport-only versus cGAMP-transport-only mutations (where mapped) can dissect dual functions. • Methotrexate sensitivity rescue: drug sensitivity restoration in SLC19A1-null cells confirms transport function rescue. • STING activation rescue: extracellular cGAMP-induced STING activation restoration confirms cGAMP transport rescue. HEK293 transduces efficiently with lentivirus and is the standard heterologous expression background for SLC19A1 biochemistry.

The choice depends on whether you are studying SLC25A27 (UCP4)'s role as a brain-expressed putative uncoupling protein or its emerging functions in neuronal mitochondrial bioenergetics. The Knockout line is appropriate for asking whether UCP4 contributes to mitochondrial uncoupling or related carrier activities, with the caveat that UCP4's principal expression is in brain. Overexpression is useful for testing uncoupling activity or studying substrate specificity in heterologous systems. Important consideration: UCP4 is principally expressed in brain — HEK293 is not the physiological context for UCP4 function. The EDITGENE Knockout in HEK293 is most useful for in vitro biochemistry, mitochondrial function studies, and as a clean background for heterologous UCP4 reconstitution. For physiological neuronal UCP4 research, neuronal cell systems are more appropriate. Rescue with wild-type or transport-deficient UCP4 enables structure-function studies.

Yes. UCP4 rescue experiments require attention to mitochondrial targeting and uncoupling activity: • Construct design: use a codon-modified SLC25A27 sequence with a small C-terminal tag (FLAG, HA). UCP4 has the canonical SLC25 6-transmembrane architecture. • Mitochondrial localization validation: confirm mitochondrial inner membrane localization before bioenergetic assays. • Activity-modulating mutants: rescue with mutations affecting predicted purine nucleotide regulatory sites can dissect regulatory inputs to UCP4 activity. • Functional readout: rescue should restore phenotypes identified during knockout characterization; mitochondrial proton leak measurements assess putative uncoupling activity. HEK293 transduces efficiently with lentivirus and supports stable rescue line generation.

The choice depends on whether you are studying SLC12A6 (KCC3)'s role as a K⁺-Cl⁻ cotransporter or modeling Andermann syndrome (agenesis of corpus callosum with peripheral neuropathy). The Knockout line is the standard tool for asking whether KCC3 is required for K⁺-Cl⁻ efflux — KCC3 is broadly expressed and contributes to cell volume regulation, ion homeostasis, and neuronal chloride extrusion. Overexpression is useful for studying transport activity or for testing disease-associated mutations. For KCC family research, the EDITGENE SLC12A6 Knockout in HEK293 is the standard mechanistic platform — HEK293 has been extensively used for KCC family biochemistry. SLC12A6 mutations cause Andermann syndrome (autosomal recessive ACCPN) — disease variant rescue enables genotype-function studies. Rescue with wild-type, transport-deficient, or phospho-mimetic (constitutively active, T991A/T1048A) KCC3 enables comprehensive structure-function and regulatory mechanism studies.

Yes. KCC3 rescue experiments are well-established for cation-chloride cotransporter research: • Construct design: use a codon-modified SLC12A6 sequence with a small C-terminal tag (FLAG, HA). KCC3 has 12 transmembrane domains with a large cytoplasmic C-terminus. • Phospho-regulatory rescue: T991A/T1048A double mutation creates constitutively active KCC3, useful for distinguishing transport from regulatory effects. • Andermann syndrome rescue: patient-derived SLC12A6 mutations enable disease genotype-function correlation. • Functional readout: rescue should restore K⁺-Cl⁻ cotransport activity measured by ⁸⁶Rb⁺ flux or cell volume regulatory volume decrease. HEK293 transduces efficiently with lentivirus and supports stable rescue line generation.

The choice depends on whether you are studying SIRT3's role as the principal mitochondrial NAD⁺-dependent deacetylase or its functions in metabolic regulation, oxidative stress response, and aging biology. The Knockout line is the standard tool for asking whether SIRT3 is required for deacetylating mitochondrial substrates — SIRT3 regulates fatty acid oxidation (LCAD, HADHA), TCA cycle (IDH2, GDH), ETC components, and antioxidant defense (SOD2). Overexpression is useful for studying SIRT3 in metabolic stress and for testing therapeutic potential. For mitochondrial sirtuin research, the EDITGENE SIRT3 Knockout in HEK293 is a workhorse mechanistic platform — HEK293 supports biochemical SIRT3 substrate characterization and structure-function studies. This product complements the parallel SIRT3 Knockout in HAP1 (also available); HEK293 is preferred for biochemistry, transfection-based reporter assays, and structure-function studies given its high transfection efficiency. Rescue with wild-type or catalytically-dead (H248Y) SIRT3 is the standard specificity control.